{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:55:44Z","timestamp":1790654144471,"version":"4.1.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:00:00Z","timestamp":1641772800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T00:00:00Z","timestamp":1641772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001320","name":"Wolfson Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002283","name":"Alzheimer\u2019s Research UK","doi-asserted-by":"publisher","award":["2018B- 001"],"award-info":[{"award-number":["2018B- 001"]}],"id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002283","name":"Alzheimer\u2019s Research UK","doi-asserted-by":"publisher","award":["ARUK-IRG2019A-003"],"award-info":[{"award-number":["ARUK-IRG2019A-003"]}],"id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/N013867\/1"],"award-info":[{"award-number":["MR\/N013867\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/ R024790\/2"],"award-info":[{"award-number":["MR\/ R024790\/2"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002283","name":"Alzheimer\u2019s Research UK","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["205167\/Z\/16\/Z"],"award-info":[{"award-number":["205167\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Depression is a common non-motor feature of Parkinson\u2019s disease (PD) which confers significant morbidity and is challenging to treat. The thalamus is a key component in the basal ganglia-thalamocortical network critical to the pathogenesis of PD and depression but the precise thalamic subnuclei involved in PD depression have not been identified. We performed structural and diffusion-weighted imaging (DWI) on 76 participants with PD to evaluate the relationship between PD depression and grey and white matter thalamic subnuclear changes. We used a thalamic segmentation method to divide the thalamus into its 50 constituent subnuclei (25 each hemisphere). Fixel-based analysis was used to calculate mean fibre cross-section (FC) for white matter tracts connected to each subnucleus. We assessed volume and FC at baseline and 14\u201320 months follow-up. A generalised linear mixed model was used to evaluate the relationship between depression, subnuclei volume and mean FC for each thalamic subnucleus. We found that depression scores in PD were associated with lower right pulvinar anterior (PuA) subnucleus volume. Antidepressant use was associated with higher right PuA volume suggesting a possible protective effect of treatment. After follow-up, depression scores were associated with reduced white matter tract macrostructure across almost all tracts connected to thalamic subnuclei. In conclusion, our work implicates the right PuA as a relevant neural structure in PD depression and future work should evaluate its potential as a therapeutic target for PD depression.<\/jats:p>","DOI":"10.1038\/s41531-021-00270-y","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T06:02:59Z","timestamp":1641794579000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Thalamic white matter macrostructure and subnuclei volumes in Parkinson\u2019s disease depression"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8317-7930","authenticated-orcid":false,"given":"R.","family":"Bhome","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Zarkali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. E. C.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. E.","family":"Iglesias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. H.","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5092-6325","authenticated-orcid":false,"given":"R. S.","family":"Weil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,10]]},"reference":[{"key":"270_CR1","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/mds.21803","volume":"23","author":"JS Reijnders","year":"2008","unstructured":"Reijnders, J. S., Ehrt, U., Weber, W. E., Aarsland, D. & Leentjens, A. F. A systematic review of prevalence studies of depression in Parkinson\u2019s disease. Mov. Disord. 23, 183\u2013189 (2008). quiz 313.","journal-title":"Mov. Disord."},{"key":"270_CR2","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1136\/jnnp.69.5.584","volume":"69","author":"KH Karlsen","year":"2000","unstructured":"Karlsen, K. H., Tandberg, E., Arsland, D. & Larsen, J. P. Health related quality of life in Parkinson\u2019s disease: a prospective longitudinal study. J. Neurol. Neurosurg. Psychiatry 69, 584\u2013589 (2000).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"270_CR3","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.parkreldis.2010.06.014","volume":"16","author":"EL Jacob","year":"2010","unstructured":"Jacob, E. L., Gatto, N. M., Thompson, A., Bordelon, Y. & Ritz, B. Occurrence of depression and anxiety prior to Parkinson\u2019s disease. Parkinsonism Relat. Disord. 16, 576\u2013581 (2010).","journal-title":"Parkinsonism Relat. Disord."},{"key":"270_CR4","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.parkreldis.2011.07.008","volume":"17","author":"A Srivastava","year":"2011","unstructured":"Srivastava, A. et al. The relation between depression and parkin genotype: the CORE-PD study. Parkinsonism Relat. Disord. 17, 740\u2013744 (2011).","journal-title":"Parkinsonism Relat. Disord."},{"key":"270_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.parkreldis.2016.11.009","volume":"35","author":"J Borgonovo","year":"2017","unstructured":"Borgonovo, J. et al. Changes in neural circuitry associated with depression at pre-clinical, pre-motor and early motor phases of Parkinson\u2019s disease. Parkinsonism Relat. Disord. 35, 17\u201324 (2017).","journal-title":"Parkinsonism Relat. Disord."},{"key":"270_CR6","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1017\/S1041610213001427","volume":"25","author":"MH Chagas","year":"2013","unstructured":"Chagas, M. H. et al. Neuroimaging of depression in Parkinson\u2019s disease: a review. Int. Psychogeriatr. 25, 1953\u20131961 (2013).","journal-title":"Int. Psychogeriatr."},{"key":"270_CR7","doi-asserted-by":"publisher","first-page":"S237","DOI":"10.1016\/S1353-8020(09)70822-3","volume":"15","author":"M DeLong","year":"2009","unstructured":"DeLong, M. & Wichmann, T. Update on models of basal ganglia function and dysfunction. Parkinsonism Relat. Disord. 15, S237\u2013S240 (2009).","journal-title":"Parkinsonism Relat. Disord."},{"key":"270_CR8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.tics.2011.12.011","volume":"16","author":"JL Price","year":"2012","unstructured":"Price, J. L. & Drevets, W. C. Neural circuits underlying the pathophysiology of mood disorders. Trends Cogn. Sci. 16, 61\u201371 (2012).","journal-title":"Trends Cogn. Sci."},{"key":"270_CR9","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.neuroimage.2009.04.059","volume":"47","author":"EF Cardoso","year":"2009","unstructured":"Cardoso, E. F. et al. Depression in Parkinson\u2019s disease: convergence from voxel-based morphometry and functional magnetic resonance imaging in the limbic thalamus. Neuroimage 47, 467\u2013472 (2009).","journal-title":"Neuroimage"},{"key":"270_CR10","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1002\/mds.26087","volume":"30","author":"X Hu","year":"2015","unstructured":"Hu, X. et al. Abnormal functional connectivity of the amygdala is associated with depression in Parkinson\u2019s disease. Mov. Disord. 30, 238\u2013244 (2015).","journal-title":"Mov. Disord."},{"key":"270_CR11","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.3174\/ajnr.A2195","volume":"31","author":"W Li","year":"2010","unstructured":"Li, W. et al. White matter microstructure changes in the thalamus in Parkinson disease with depression: a diffusion tensor MR imaging study. Am. J. Neuroradiol. 31, 1861\u20131866 (2010).","journal-title":"Am. J. Neuroradiol."},{"key":"270_CR12","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1093\/brain\/awh445","volume":"128","author":"P Remy","year":"2005","unstructured":"Remy, P., Doder, M., Lees, A., Turjanski, N. & Brooks, D. Depression in Parkinson\u2019s disease: loss of dopamine and noradrenaline innervation in the limbic system. Brain 128, 1314\u20131322 (2005).","journal-title":"Brain"},{"key":"270_CR13","doi-asserted-by":"publisher","first-page":"448","DOI":"10.4088\/JCP.09m05393blu","volume":"72","author":"T Frodl","year":"2011","unstructured":"Frodl, T. et al. Different effects of mirtazapine and venlafaxine on brain activation: an open randomized controlled fMRI study. J. Clin. Psychiatry 72, 448\u2013457 (2011).","journal-title":"J. Clin. Psychiatry"},{"key":"270_CR14","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/s41380-017-0009-x","volume":"24","author":"C Kraus","year":"2019","unstructured":"Kraus, C. et al. The pulvinar nucleus and antidepressant treatment: dynamic modeling of antidepressant response and remission with ultra-high field functional MRI. Mol. Psychiatry 24, 746\u2013756 (2019).","journal-title":"Mol. Psychiatry"},{"key":"270_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.pscychresns.2016.04.013","volume":"252","author":"R Tadayonnejad","year":"2016","unstructured":"Tadayonnejad, R. et al. Pharmacological modulation of pulvinar resting-state regional oscillations and network dynamics in major depression. Psychiatry Res. Neuroimaging 252, 10\u201318 (2016).","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"270_CR16","doi-asserted-by":"publisher","first-page":"458","DOI":"10.2174\/1570159X1304150831121909","volume":"13","author":"N Dusi","year":"2015","unstructured":"Dusi, N., Barlati, S., Vita, A. & Brambilla, P. Brain structural effects of antidepressant treatment in major depression. Curr. Neuropharmacol. 13, 458\u2013465 (2015).","journal-title":"Curr. Neuropharmacol."},{"key":"270_CR17","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1001\/archpsyc.58.7.631","volume":"58","author":"AL Brody","year":"2001","unstructured":"Brody, A. L. et al. Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. Arch. Gen. Psychiatry 58, 631\u2013640 (2001).","journal-title":"Arch. Gen. Psychiatry"},{"key":"270_CR18","doi-asserted-by":"publisher","first-page":"S503","DOI":"10.1016\/j.euroneuro.2004.09.001","volume":"14","author":"P Fossati","year":"2004","unstructured":"Fossati, P., Radtchenko, A. & Boyer, P. Neuroplasticity: from MRI to depressive symptoms. Eur. Neuropsychopharmacol. 14, S503\u2013S510 (2004).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"270_CR19","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/npp.2013.2","volume":"38","author":"K Ohira","year":"2013","unstructured":"Ohira, K., Takeuchi, R., Shoji, H. & Miyakawa, T. Fluoxetine-induced cortical adult neurogenesis. Neuropsychopharmacology 38, 909\u2013920 (2013).","journal-title":"Neuropsychopharmacology"},{"key":"270_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10676-5","volume":"7","author":"J Liu","year":"2017","unstructured":"Liu, J. et al. Brain grey matter volume alterations associated with antidepressant response in major depressive disorder. Sci. Rep. 7, 10464 (2017).","journal-title":"Sci. Rep."},{"key":"270_CR21","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3233\/JPD-171204","volume":"8","author":"HE Morgan","year":"2018","unstructured":"Morgan, H. E., Ledbetter, C. R., Ferrier, C., Zweig, R. M. & Disbrow, E. A. Altered cortico-limbic network connectivity in Parkinsonian depression: the effect of antidepressants. J. Parkinsons Dis. 8, 429\u2013440 (2018).","journal-title":"J. Parkinsons Dis."},{"key":"270_CR22","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.neuroimage.2018.08.012","volume":"183","author":"JE Iglesias","year":"2018","unstructured":"Iglesias, J. E. et al. A probabilistic atlas of the human thalamic nuclei combining ex vivo MRI and histology. Neuroimage 183, 314\u2013326 (2018).","journal-title":"Neuroimage"},{"key":"270_CR23","doi-asserted-by":"publisher","unstructured":"Zarkali, A., McColgan, P., Leyland, L. A., Lees, A. J. & Weil, R. S. Visual dysfunction predicts cognitive impairment and white matter degeneration in Parkinson\u2019s disease. Mov. Disord. https:\/\/doi.org\/10.1002\/mds.28477 (2021)","DOI":"10.1002\/mds.28477"},{"key":"270_CR24","doi-asserted-by":"publisher","unstructured":"Zarkali, A., McColgan, P., Leyland, L. A., Lees, A. J. & Weil, R. S. Longitudinal thalamic white and gray matter changes associated with visual hallucinations in Parkinson\u2019s disease. J. Neurol. Neurosurg. Psychiatry https:\/\/doi.org\/10.1136\/jnnp-2021-326630 (2021)","DOI":"10.1136\/jnnp-2021-326630"},{"key":"270_CR25","doi-asserted-by":"crossref","unstructured":"Starkstein, S. E. et al. Depression and cognitive impairment in Parkinson\u2019s disease. Brain 112, 1141\u20131153.","DOI":"10.1093\/brain\/112.5.1141"},{"key":"270_CR26","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1517\/14656566.2012.736490","volume":"13","author":"U Bonuccelli","year":"2012","unstructured":"Bonuccelli, U. et al. A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson\u2019s disease. Expert Opin. Pharmacother. 13, 2269\u20132280 (2012).","journal-title":"Expert Opin. Pharmacother."},{"key":"270_CR27","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.neubiorev.2008.09.002","volume":"33","author":"SJ Broyd","year":"2009","unstructured":"Broyd, S. J. et al. Default-mode brain dysfunction in mental disorders: a systematic review. Neurosci. Biobehav. Rev. 33, 279\u2013296 (2009).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"270_CR28","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/nrn1747","volume":"6","author":"ML Kringelbach","year":"2005","unstructured":"Kringelbach, M. L. The human orbitofrontal cortex: linking reward to hedonic experience. Nat. Rev. Neurosci. 6, 691\u2013702 (2005).","journal-title":"Nat. Rev. Neurosci."},{"key":"270_CR29","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.neuron.2014.10.049","volume":"84","author":"PH Rudebeck","year":"2014","unstructured":"Rudebeck, P. H. & Murray, E. A. The orbitofrontal oracle: cortical mechanisms for the prediction and evaluation of specific behavioral outcomes. Neuron 84, 1143\u20131156 (2014).","journal-title":"Neuron"},{"key":"270_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/srep34777","volume":"6","author":"Y Hakamata","year":"2016","unstructured":"Hakamata, Y. et al. The functional activity and effective connectivity of pulvinar are modulated by individual differences in threat-related attentional bias. Sci. Rep. 6, 34777 (2016).","journal-title":"Sci. Rep."},{"key":"270_CR31","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1017\/S0033291799003141","volume":"31","author":"A Schrag","year":"2001","unstructured":"Schrag, A., Jahanshahi, M. & Quinn, N. P. What contributes to depression in Parkinson\u2019s disease? Psychol. Med. 31, 65\u201373 (2001).","journal-title":"Psychol. Med."},{"key":"270_CR32","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0197-4580(01)00269-X","volume":"23","author":"U Rub","year":"2002","unstructured":"Rub, U. et al. Parkinson\u2019s disease: the thalamic components of the limbic loop are severely impaired by alpha-synuclein immunopositive inclusion body pathology. Neurobiol. Aging 23, 245\u2013254 (2002).","journal-title":"Neurobiol. Aging"},{"key":"270_CR33","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.brainresbull.2008.08.014","volume":"78","author":"D Brooks","year":"2009","unstructured":"Brooks, D. & Halliday, G. M. Intralaminar nuclei of the thalamus in Lewy body diseases. Brain Res. Bull. 78, 97\u2013104 (2009).","journal-title":"Brain Res. Bull."},{"key":"270_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04497-x","volume":"9","author":"S Honjoh","year":"2018","unstructured":"Honjoh, S. et al. Regulation of cortical activity and arousal by the matrix cells of the ventromedial thalamic nucleus. Nat. Commun. 9, 2100 (2018).","journal-title":"Nat. Commun."},{"key":"270_CR35","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1002\/mds.21376","volume":"22","author":"KM Miller","year":"2007","unstructured":"Miller, K. M. et al. Depression symptoms in movement disorders: comparing Parkinson\u2019s disease, dystonia, and essential tremor. Mov. Disord. 22, 666\u2013672 (2007).","journal-title":"Mov. Disord."},{"key":"270_CR36","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/jnnp.55.5.377","volume":"55","author":"SE Starkstein","year":"1992","unstructured":"Starkstein, S. E., Mayberg, H. S., Leiguarda, R., Preziosi, T. J. & Robinson, R. G. A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson\u2019s disease. J. Neurol. Neurosurg. Psychiatry 55, 377\u2013382 (1992).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"270_CR37","doi-asserted-by":"publisher","first-page":"e0203303","DOI":"10.1371\/journal.pone.0203303","volume":"13","author":"Y Lee","year":"2018","unstructured":"Lee, Y. et al. The presence of depression in de novo Parkinson\u2019s disease reflects poor motor compensation. PLoS ONE 13, e0203303 (2018).","journal-title":"PLoS ONE"},{"key":"270_CR38","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/S1353-8020(09)70769-2","volume":"15","author":"DW Dickson","year":"2009","unstructured":"Dickson, D. W. et al. Neuropathology of non-motor features of Parkinson disease. Parkinsonism Relat. Disord. 15, S1\u2013S5 (2009).","journal-title":"Parkinsonism Relat. Disord."},{"key":"270_CR39","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/mds.25825","volume":"29","author":"A Iranzo","year":"2014","unstructured":"Iranzo, A. et al. Neuropathology of prodromal Lewy body disease. Mov. Disord. 29, 410\u2013415 (2014).","journal-title":"Mov. Disord."},{"key":"270_CR40","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3233\/JPD-191683","volume":"9","author":"S Cerri","year":"2019","unstructured":"Cerri, S., Mus, L. & Blandini, F. Parkinson\u2019s disease in women and men: what\u2019s the difference? J. Parkinsons Dis. 9, 501\u2013515 (2019).","journal-title":"J. Parkinsons Dis."},{"key":"270_CR41","doi-asserted-by":"publisher","first-page":"e1525","DOI":"10.1212\/WNL.0000000000009014","volume":"94","author":"A Zarkali","year":"2020","unstructured":"Zarkali, A. et al. Fiber-specific white matter reductions in Parkinson hallucinations and visual dysfunction. Neurology 94, e1525\u2013e1538 (2020).","journal-title":"Neurology"},{"key":"270_CR42","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.nicl.2017.02.012","volume":"14","author":"JW Chung","year":"2017","unstructured":"Chung, J. W. et al. Parkinson\u2019s disease diffusion MRI is not affected by acute antiparkinsonian medication. Neuroimage Clin. 14, 417\u2013421 (2017).","journal-title":"Neuroimage Clin."},{"key":"270_CR43","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond, A. S. & Snaith, R. P. The hospital anxiety and depression scale. Acta Psychiatr. Scand. 67, 361\u2013370 (1983).","journal-title":"Acta Psychiatr. Scand."},{"key":"270_CR44","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/00002826-200211000-00008","volume":"25","author":"J Marinus","year":"2002","unstructured":"Marinus, J., Leentjens, A. F., Visser, M., Stiggelbout, A. M. & van Hilten, J. J. Evaluation of the hospital anxiety and depression scale in patients with Parkinson\u2019s disease. Clin. Neuropharmacol. 25, 318\u2013324 (2002).","journal-title":"Clin. Neuropharmacol."},{"key":"270_CR45","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","volume":"25","author":"CL Tomlinson","year":"2010","unstructured":"Tomlinson, C. L. et al. Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease. Mov. Disord. 25, 2649\u20132653 (2010).","journal-title":"Mov. Disord."},{"key":"270_CR46","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.neuroimage.2012.01.021","volume":"62","author":"B Fischl","year":"2012","unstructured":"Fischl, B. FreeSurfer. Neuroimage 62, 774\u2013781 (2012).","journal-title":"Neuroimage"},{"key":"270_CR47","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.neuroimage.2016.08.016","volume":"142","author":"J Veraart","year":"2016","unstructured":"Veraart, J. et al. Denoising of diffusion MRI using random matrix theory. Neuroimage 142, 394\u2013406 (2016).","journal-title":"Neuroimage"},{"key":"270_CR48","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/mrm.26054","volume":"76","author":"E Kellner","year":"2016","unstructured":"Kellner, E., Dhital, B., Kiselev, V. G. & Reisert, M. Gibbs-ringing artifact removal based on local subvoxel-shifts. Magn. Reson. Med. 76, 1574\u20131581 (2016).","journal-title":"Magn. Reson. Med."},{"key":"270_CR49","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1109\/TMI.2010.2046908","volume":"29","author":"NJ Tustison","year":"2010","unstructured":"Tustison, N. J. et al. N4ITK: improved N3 bias correction. IEEE Trans. Med. Imaging 29, 1310\u20131320 (2010).","journal-title":"IEEE Trans. Med. Imaging"},{"key":"270_CR50","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.neuroimage.2009.11.044","volume":"50","author":"D Holland","year":"2010","unstructured":"Holland, D., Kuperman, J. M. & Dale, A. M. Efficient correction of inhomogeneous static magnetic field-induced distortion in Echo Planar Imaging. Neuroimage 50, 175\u2013183 (2010).","journal-title":"Neuroimage"},{"key":"270_CR51","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/S1053-8119(03)00336-7","volume":"20","author":"JL Andersson","year":"2003","unstructured":"Andersson, J. L., Skare, S. & Ashburner, J. How to correct susceptibility distortions in spin-echo echo-planar images: application to diffusion tensor imaging. Neuroimage 20, 870\u2013888 (2003).","journal-title":"Neuroimage"},{"key":"270_CR52","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.neuroimage.2015.10.019","volume":"125","author":"JLR Andersson","year":"2016","unstructured":"Andersson, J. L. R. & Sotiropoulos, S. N. An integrated approach to correction for off-resonance effects and subject movement in diffusion MR imaging. Neuroimage 125, 1063\u20131078 (2016).","journal-title":"Neuroimage"},{"key":"270_CR53","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.neuroimage.2015.11.006","volume":"125","author":"MS Graham","year":"2016","unstructured":"Graham, M. S., Drobnjak, I. & Zhang, H. Realistic simulation of artefacts in diffusion MRI for validating post-processing correction techniques. Neuroimage 125, 1079\u20131094 (2016).","journal-title":"Neuroimage"},{"key":"270_CR54","doi-asserted-by":"publisher","first-page":"116137","DOI":"10.1016\/j.neuroimage.2019.116137","volume":"202","author":"JD Tournier","year":"2019","unstructured":"Tournier, J. D. et al. MRtrix3: a fast, flexible and open software framework for medical image processing and visualisation. Neuroimage 202, 116137 (2019).","journal-title":"Neuroimage"},{"key":"270_CR55","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.1016\/j.neuroimage.2011.10.045","volume":"59","author":"D Raffelt","year":"2012","unstructured":"Raffelt, D. et al. Apparent fibre density: a novel measure for the analysis of diffusion-weighted magnetic resonance images. Neuroimage 59, 3976\u20133994 (2012).","journal-title":"Neuroimage"},{"key":"270_CR56","unstructured":"Hollander, T., Raffelt, D., & Connelly, A. Unsupervised 3-tissue response function estimation from single-shell or multi-shell diffusion MR data without a co-registered T1 image. Presented at the ISMRM Workshop Break Barriers Diffus MRI, Lisbon, Portugal, September 2016"},{"key":"270_CR57","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1093\/brain\/awx355","volume":"141","author":"R Mito","year":"2018","unstructured":"Mito, R. et al. Fibre-specific white matter reductions in Alzheimer\u2019s disease and mild cognitive impairment. Brain 141, 888\u2013902 (2018).","journal-title":"Brain"},{"key":"270_CR58","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.neuroimage.2009.08.039","volume":"49","author":"S Jbabdi","year":"2010","unstructured":"Jbabdi, S., Behrens, T. E. & Smith, S. M. Crossing fibres in tract-based spatial statistics. Neuroimage 49, 249\u2013256 (2010).","journal-title":"Neuroimage"},{"key":"270_CR59","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1002\/mrm.22924","volume":"65","author":"JD Tournier","year":"2011","unstructured":"Tournier, J. D., Mori, S. & Leemans, A. Diffusion tensor imaging and beyond. Magn. Reson. Med. 65, 1532\u20131556 (2011).","journal-title":"Magn. Reson. Med."},{"key":"270_CR60","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.neuroimage.2016.09.029","volume":"144","author":"DA Raffelt","year":"2017","unstructured":"Raffelt, D. A. et al. Investigating white matter fibre density and morphology using fixel-based analysis. Neuroimage 144, 58\u201373 (2017).","journal-title":"Neuroimage"},{"key":"270_CR61","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.cmpb.2009.09.002","volume":"98","author":"M Modat","year":"2010","unstructured":"Modat, M. et al. Fast free-form deformation using graphics processing units. Comput. Methods Prog. Biomed. 98, 278\u2013284 (2010).","journal-title":"Comput. Methods Prog. Biomed."},{"key":"270_CR62","doi-asserted-by":"publisher","first-page":"S152","DOI":"10.1016\/S1353-8020(09)70804-1","volume":"15","author":"GM Halliday","year":"2009","unstructured":"Halliday, G. M. Thalamic changes in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 15, S152\u2013S155 (2009).","journal-title":"Parkinsonism Relat. Disord."},{"key":"270_CR63","doi-asserted-by":"publisher","first-page":"111273","DOI":"10.1016\/j.pscychresns.2021.111273","volume":"312","author":"C Owens-Walton","year":"2021","unstructured":"Owens-Walton, C. et al. Structural and functional neuroimaging changes associated with cognitive impairment and dementia in Parkinson\u2019s disease. Psychiatry Res. Neuroimaging 312, 111273 (2021).","journal-title":"Psychiatry Res. Neuroimaging"},{"key":"270_CR64","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-021-00270-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-021-00270-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-021-00270-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T20:09:23Z","timestamp":1726430963000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-021-00270-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,10]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["270"],"URL":"https:\/\/doi.org\/10.1038\/s41531-021-00270-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.05.07.21256793","asserted-by":"object"}]},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,10]]},"assertion":[{"value":"1 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.B., A.Z., G.E.C.T., J.E.I. and J.H.C. report no competing interests. R.S.W. has received speaker honoraria from GE Healthcare and honoraria from Britannia.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}